SG161270A1 - Association between ferroquine and an artemisinine derivative for treating malaria - Google Patents

Association between ferroquine and an artemisinine derivative for treating malaria

Info

Publication number
SG161270A1
SG161270A1 SG201002562-5A SG2010025625A SG161270A1 SG 161270 A1 SG161270 A1 SG 161270A1 SG 2010025625 A SG2010025625 A SG 2010025625A SG 161270 A1 SG161270 A1 SG 161270A1
Authority
SG
Singapore
Prior art keywords
ferroquine
association
artemisinine
derivative
concerns
Prior art date
Application number
SG201002562-5A
Other languages
English (en)
Inventor
Laurent Fraisse
Daniel Ter-Minassian
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of SG161270A1 publication Critical patent/SG161270A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG201002562-5A 2005-04-20 2006-04-18 Association between ferroquine and an artemisinine derivative for treating malaria SG161270A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0503932A FR2884715B1 (fr) 2005-04-20 2005-04-20 Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme

Publications (1)

Publication Number Publication Date
SG161270A1 true SG161270A1 (en) 2010-05-27

Family

ID=35385843

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201002562-5A SG161270A1 (en) 2005-04-20 2006-04-18 Association between ferroquine and an artemisinine derivative for treating malaria

Country Status (30)

Country Link
US (1) US20120258945A1 (es)
EP (1) EP1874293A1 (es)
JP (1) JP5148478B2 (es)
KR (1) KR20080009088A (es)
CN (2) CN102836163A (es)
AP (1) AP2782A (es)
AR (1) AR054253A1 (es)
AU (1) AU2006238506B2 (es)
BR (1) BRPI0610851A2 (es)
CA (1) CA2605385A1 (es)
CR (1) CR9425A (es)
DO (1) DOP2006000092A (es)
EA (1) EA012630B1 (es)
FR (1) FR2884715B1 (es)
GT (1) GT200600157A (es)
HN (1) HN2006015130A (es)
IL (1) IL186048A0 (es)
MA (1) MA29451B1 (es)
MX (1) MX2007012645A (es)
MY (1) MY145581A (es)
NO (1) NO20075920L (es)
NZ (1) NZ562117A (es)
PA (1) PA8669801A1 (es)
PE (2) PE20110119A1 (es)
SG (1) SG161270A1 (es)
TN (1) TNSN07359A1 (es)
TW (1) TWI387456B (es)
UA (1) UA96414C2 (es)
WO (1) WO2006111647A1 (es)
ZA (1) ZA200708800B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926993B1 (fr) * 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
FR2951945B1 (fr) 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
FR2961209B1 (fr) * 2010-06-11 2013-03-01 Sanofi Aventis Procede de synthese de la ferroquine par amination reductrice convergente.
FR2989588A1 (fr) * 2012-04-19 2013-10-25 Centre Nat Rech Scient Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
CN105250295B (zh) * 2014-07-07 2018-12-25 广州中医药大学科技产业园有限公司 一种联合用药物及其作为免疫调节剂的应用
US10512652B2 (en) 2015-07-20 2019-12-24 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
CN107802755A (zh) * 2017-11-08 2018-03-16 江西龙卿堂科技有限公司 一种具有防蚊防疟作用的青蒿软膏
KR102073961B1 (ko) * 2018-11-16 2020-02-05 (주)프론트바이오 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물
US20240207251A1 (en) * 2021-04-26 2024-06-27 Min Bo SHIM Pharmaceutical composition containing artesunate or salt thereof and pyronaridine or salt thereof, for antipyresis, anti-inflammatory efficacy, anti-viral efficacy and treatment or prevention of covid-19, and method using same
CN113952360B (zh) * 2021-09-14 2023-03-10 上海交通大学 一种亚铁离子在治疗疟疾的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (es) * 1987-05-08 1990-03-24 Hoechst India
AP2006003557A0 (en) * 2003-09-04 2006-04-30 Cipla Ltd Antimalarial compositions and process thereof.

Also Published As

Publication number Publication date
CA2605385A1 (fr) 2006-10-26
TW200716092A (en) 2007-05-01
UA96414C2 (ru) 2011-11-10
PE20110119A1 (es) 2011-03-08
CN102836163A (zh) 2012-12-26
MA29451B1 (fr) 2008-05-02
MY145581A (en) 2012-02-29
HN2006015130A (es) 2010-08-19
DOP2006000092A (es) 2006-11-15
KR20080009088A (ko) 2008-01-24
NO20075920L (no) 2007-11-16
GT200600157A (es) 2006-11-07
AU2006238506B2 (en) 2012-03-01
FR2884715A1 (fr) 2006-10-27
AU2006238506A1 (en) 2006-10-26
EP1874293A1 (fr) 2008-01-09
CN101163470A (zh) 2008-04-16
JP5148478B2 (ja) 2013-02-20
AR054253A1 (es) 2007-06-13
WO2006111647A1 (fr) 2006-10-26
PE20061314A1 (es) 2006-12-27
NZ562117A (en) 2010-01-29
TWI387456B (zh) 2013-03-01
ZA200708800B (en) 2009-01-28
CR9425A (es) 2008-02-20
MX2007012645A (es) 2007-12-13
PA8669801A1 (es) 2006-11-09
TNSN07359A1 (en) 2008-12-31
EA200702282A1 (ru) 2008-02-28
US20120258945A1 (en) 2012-10-11
JP2008536900A (ja) 2008-09-11
EA012630B1 (ru) 2009-10-30
AP2782A (en) 2013-10-31
IL186048A0 (en) 2008-02-09
FR2884715B1 (fr) 2007-06-15
AP2007004211A0 (en) 2007-10-31
BRPI0610851A2 (pt) 2010-08-03

Similar Documents

Publication Publication Date Title
SG161270A1 (en) Association between ferroquine and an artemisinine derivative for treating malaria
NL300809I2 (es)
GEP20094605B (en) Pyrazole derivatives, compositions containing such compounds and methods of use thereof
TW200730502A (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
GEP20094826B (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
IL238479A0 (en) c2 th5 receptor modulator preparations and methods of use
EP2269608A3 (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
ATE450533T1 (de) Carboxamidderivate
EP1691789A4 (en) CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
GEP20084391B (en) Pyrazoles and methods of making and using the same
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
TW200613243A (en) Novel compounds
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
TW200745044A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
GB0109122D0 (en) Novel compounds
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
TNSN08529A1 (en) Inhibitors of akt (protein kinase b)
MXPA03010761A (es) Combinaciones farmaceuticas.
EP1784173A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METABOLIC BONE DISEASES CONTAINING ALPHA-ARYLMETHOXYACRYLATE DERIVATIVES
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
RS20060239A (en) Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics
TW200733963A (en) Cough inhibitor
WO2008004100A3 (en) Therapeutic compounds
MX2008011769A (es) Derivados de ftalazinona pirazol, su fabricacion y uso como agentes farmaceuticos.
WO2004041190A3 (en) Composition for the treatment of macular degenration